ANTX
AN2 Therapeutics Inc
5.10$
+3.1%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | |
| – | -79.5% | +180.9% | +74.6% | +85.9% | -26.2% | -38.8% | |
| – | -27.0% | +269.0% | +173.2% | +15.8% | -4.7% | -5.2% | |
| – | -76.6% | +196.2% | +95.9% | +64.8% | -21.7% | -30.1% | |
| – | – | – | – | – | – | – | |
| – | – | +2,200.0% | +644.9% | – | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | -113.5% | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | -34.1% | -1,188.0% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.